[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2019/49061,2019,A1Locationinpatent:Page/Pagecolumn214;215
1151767-58-6
1481-68-1
2106-49-2
2339-78-8
1805029-24-6
1360438-72-7
54226-23-2 | Methyl 3,4-diamino-5-nitrobenzoate | AA003A36 | MFCD25964400
885698-95-3 | 2-Methyl-2H-indazole-4-boronic acid pinacol ester | AA003A6W | MFCD11109437
75172-66-6 | (S)-2-Hydroxy-2-(4-methoxyphenyl)acetic acid | AA003AA6 | MFCD00004233
34374-88-4 | 2,4,6-Trihydroxybenzene-1,3,5-tricarbaldehyde | AA003AFH | MFCD24713435
303-14-0 | N,N,β-Trimethyl-10H-phenothiazine-10-ethanamine | AA003AL7 | MFCD22460468
924858-73-1 | Phenol, 2-methyl-5-(1H-tetrazol-1-yl)- | AA003AR6 | MFCD08848230
51096-49-2 | (S)-(+)-2-Benzylamino-1-phenylethanol | AA003AW7 | MFCD03427123
64262-23-3 | 1-Propylpiperazine dihydrobromide | AA003AZ5 | MFCD00051992
4107-65-7 | 2,4-Dimethoxybenzonitrile | AA003B25 | MFCD00001786
31594-45-3 | 2-Ethoxy-5-nitropyridine | AA003B4Z | MFCD01646181